Ribavirin for respiratory syncytial virus lower respiratory tract infection: A systematic overview

Archives of Pediatrics and Adolescent Medicine

Volumn 150, Issue 9, 1996, Pages 942-947

  Randolph, Adrienne G ^a   Wang, Elaine E L ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HOSPITALIZATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LOWER RESPIRATORY TRACT INFECTION; LUNG VENTILATION; META ANALYSIS; MORTALITY; OXYGEN THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

EID: 0029832166     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.1996.02170340056011     Document Type: Article

References (33)

1. American Academy of Pediatrics Committee on Infectious Diseases. Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics. 1993;92:501-504.
2. Zucker AR, Meadow WL. Pediatric critical physicians' attitudes about guidelines for the use of ribavirin in critically ill children with respiratory syncytial virus pneumonia. Crit Care Med. 1995;23:767-772.
3. Law BJ, DeCarvalho V. Respiratory syncytial virus infections in hospitalized Canadian children: regional differences in patient population and management practices. Pediatr Infect Dis J. 1993;12:659-663.
4. Wald ER, Dashefsky B. Ribavirin: Red Book Committee recommendations questioned. Pediatrics. 1994;94:672-673.
5. Turner RB. Red Book Committee recommendations on ribavirin challenged. Pediatrics. 1994;93:873.
6. Wald ER, Dashefsky B, Green M. In re ribavirin: a case of premature adjudication? J Pediatr. 1988;112:154-158.
7. Decker JA, Shultz RA. Interim report. In: Hazard Evaluation and Technical Assistance. Washington, DC: NIOSH; 1992.
8. McBride JT. Study design considerations for ribavirin: efficacy studies. Pediatr Infect Dis J. 1990;9(suppl):S74-S78.
9. Cook DJ, Sackett DL, Spitzer WO. Methodological guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol. 1995;48:167-171.
10. Oxman A. Preparing and maintaining systematic reviews. In: Sackett DL, ed. The Cochrane Collaboration Handbook. Oxford, England: Cochrane Collaboration; 1994.
11. International Agency for Research on Cancer. Statistical Methods in Cancer Research. Lyons, France: IARC Scientific Publications; 1980:1. IARC publication 32.
12. Bracken MB. Statistical methods for analysis of effects of treatment in overviews of randomized trials. In: Sinclair JC, Bracken MB, eds. Effective Care of the Newborn Infant. Oxford, England: Oxford University Press; 1992:13-18.
13. Thompson SG, Pocock SJ. Can meta-analyses be trusted? Lancet. 1991;338: 1127-1130.
14. Smith DW, Frankel LR, Mathers LH, Tang AT, Ariagno RL, Prober CG. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med. 1991;325:24-29.
15. Taber LH, Knight V, Gilbert BE, et al. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics. 1983;72:613-618.
16. Rodriguez WJ, Kim HW, Brandt CD, et al. Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease. Pediatr Infect Dis J. 1987;6:159-163.
17. Meert KL. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Crit Care Med. 1994;22:566-572.
18. Janai HK, Harris HR, Zaleska M, et al. Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J. 1993;12:214-218.
19. Hall CB, McBride JT, Walsh EE, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection: a randomized double-blind study. N Engl J Med. 1983;308:1443-1447.
20. Hall CB, McBride JT, Gala CL, Hildreth SW, Schnabel KC. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA. 1985;254:3047-3051.
21. Groothuis JR, Woodin KA, Katz R, et al. Early ribavirin treatment of respiratory syncytial viral infection in high risk children. J Pediatr. 1990;117:792-798.
22. Englund JA, Piedra PA, Ahn YM, Gilbert BE, Hiatt P. High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection. J Pediatr. 1994;125:635-641.
23. Rosner IK, Welliver RC, Edelson PJ, Geraci-Ciardullo K, Sun M. Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection. J Infect Dis. 1987;155:1043-1047.
24. Edelson PJ. Clinical studies with ribavirin. Pediatr Infect Dis J. 1990;9(suppl): S71-S73.
25. Barry W, Cockburn F, Cornall R, Price JF, Sutherland G, Vardag A. Ribavirin aerosol for acute bronchiolitis. Arch Dis Child. 1986;61:593-597.
26. Moler FW, Bandy KP, Custer JR. Ribavirin for severe RSV infection. N Engl J Med. 1991;325:1884-1885.
27. Sullivan BJ. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med. 1991;325:1885.
28. Stretton M, Ajizian SJ, Mitchell I, Newth CJL. Intensive care course and outcome of patients infected with respiratory syncytial virus. Pediatr Pulmonol. 1992;13:143-150.
29. Baba Y, Hayashida M, Yasunami J, Takamatsu I, Adachi K, Toyoshima K. Bronchoconstrictive effect of ultrasonic nebulized distilled water on asthmatic children. J Asthma. 1989;26:299-307.
30. Cheney FW, Butler J. The effects of ultrasonically-produced aerosols on airway resistance in man. Anesthesiology. 1968;29:1099-1106.
31. Sheppard D, Rizk NW, Boushey HA, Bethel RA. Mechanism of cough and bronchoconstriction induced by distilled water aerosol. Am Rev Respir Dis. 1983; 127:691-694.
32. McBride JT, Wooden KA, Katz R, et al. Ribavirin therapy for acute bronchiolitis: need for appropriate controls. J Pediatr. 1991;119:510.
33. American Academy of Pediatrics Committee on Infectious Diseases. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics. 1996;97:137-140.